The Malaghan Institute of Medical Research, in collaboration with Wellington Zhaotai Therapies Limited, today announced results of its phase 1 dose escalation trial of a new third generation anti-CD19 ...
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810 Sixty-nine ...
Educational Interventions for the Timely Diagnosis of Pediatric Patients With Cancer: A Scoping Review Data from 36 WHO-defined European countries (27 high-income, nine upper-middle-income) observed a ...
T cell therapy has transformed the treatment landscape for several hematologic malignancies, with FDA-approved products ...
Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific ...
In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma (LBCL) who have different levels ...
Please provide your email address to receive an email when new articles are posted on . ATA3219 is an allogeneic CAR T-cell therapy being investigated in the treatment of SLE with lupus nephritis. The ...
Please provide your email address to receive an email when new articles are posted on . Most patients with B-cell lymphomas who relapsed after CAR T-cell therapy responded to the novel, ...
Introduction Cell surface proteins are essential regulators of cell communication, mediating immune activation, cell adhesion ...
WEDNESDAY, Sept. 2, 2026 (HealthDay News) -- For women with autoimmune disease who had received autologous CD19-chimeric antigen receptor (CAR) T-cell therapy, pregnancies seem to be uncomplicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results